312 related articles for article (PubMed ID: 19467582)
1. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.
Vitiello B; Correll C; van Zwieten-Boot B; Zuddas A; Parellada M; Arango C
Eur Neuropsychopharmacol; 2009 Sep; 19(9):629-35. PubMed ID: 19467582
[TBL] [Abstract][Full Text] [Related]
2. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
Zuddas A; Zanni R; Usala T
Eur Neuropsychopharmacol; 2011 Aug; 21(8):600-20. PubMed ID: 21550212
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
[TBL] [Abstract][Full Text] [Related]
4. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
Correll CU
J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
[TBL] [Abstract][Full Text] [Related]
5. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
6. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotics in children and adolescents.
Campbell M; Rapoport JL; Simpson GM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):537-45. PubMed ID: 10230185
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotic tolerability and switching strategies in bipolar disorder.
Liauw SS; McIntyre RS
Expert Opin Pharmacother; 2010 Dec; 11(17):2827-37. PubMed ID: 20726821
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
Kranzler HN; Cohen SD
Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
[TBL] [Abstract][Full Text] [Related]
11. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
Saxena K; Chang K; Steiner H
Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic agents in the treatment of bipolar mania.
Tohen M; Vieta E
Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of psychosis in the elderly.
Sable JA; Jeste DV
J Nutr Health Aging; 2003; 7(6):421-7. PubMed ID: 14625622
[TBL] [Abstract][Full Text] [Related]
15. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
16. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
17. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
[TBL] [Abstract][Full Text] [Related]
18. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.
Correll CU; Penzner JB; Parikh UH; Mughal T; Javed T; Carbon M; Malhotra AK
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):177-206. PubMed ID: 16321730
[TBL] [Abstract][Full Text] [Related]
19. [Use of antipsychotics in first line].
Stefos G
Rev Med Brux; 2004 Sep; 25(4):A302-7. PubMed ID: 15516061
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
